{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:46:33Z","timestamp":1788871593303,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":676,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS064330"],"award-info":[{"award-number":["NS064330"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS086134"],"award-info":[{"award-number":["NS086134"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000350","name":"Core","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000350","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1038\/mt.2014.152","type":"journal-article","created":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T07:18:31Z","timestamp":1407136711000},"page":"2028-2037","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Normalization and Improvement of CNS Deficits in Mice With Hurler Syndrome After Long-term Peripheral Delivery of BBB-targeted Iduronidase"],"prefix":"10.1016","volume":"22","author":[{"given":"Salim S","family":"El-Amouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Fen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roscoe O","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2014.152_bib1","series-title":"The Online Metabolic and Molecular Bases of Inherited Disease","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2007"},{"key":"10.1038\/mt.2014.152_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11011-012-9302-1","article-title":"Mucopolysaccharidosis type I: current knowledge on its pathophysiological mechanisms","volume":"27","author":"Campos","year":"2012","journal-title":"Metab Brain Dis"},{"key":"10.1038\/mt.2014.152_bib3","doi-asserted-by":"crossref","first-page":"884","DOI":"10.2174\/138920111795542679","article-title":"Cell- and gene-based therapeutic approaches for neurological deficits in mucopolysaccharidoses","volume":"12","author":"Pan","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1038\/mt.2014.152_bib4","doi-asserted-by":"crossref","first-page":"14944","DOI":"10.1073\/pnas.95.25.14944","article-title":"Mature monocytic cells enter tissues and engraft","volume":"95","author":"Kennedy","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2014.152_bib5","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1056\/NEJMoa032613","article-title":"Cord-blood transplants from unrelated donors in patients with Hurler's syndrome","volume":"350","author":"Staba","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2014.152_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1750-1172-6-55","article-title":"Enzyme replacement therapy and\/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure","volume":"6","author":"de Ru","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"10.1038\/mt.2014.152_bib7","series-title":"Enzyme-Replacement Therapies for Lysosomal Storage Diseases","author":"Ratko","year":"2013"},{"key":"10.1038\/mt.2014.152_bib8","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/stem.716","article-title":"Concise review: managing genotoxicity in the therapeutic modification of stem cells","volume":"29","author":"Baum","year":"2011","journal-title":"Stem Cells"},{"key":"10.1038\/mt.2014.152_bib9","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1182\/blood-2010-04-278234","article-title":"Gene therapy augments the efficacy of hematopoietic cell transplantation and fully corrects mucopolysaccharidosis type I phenotype in the mouse model","volume":"116","author":"Visigalli","year":"2010","journal-title":"Blood"},{"key":"10.1038\/mt.2014.152_bib10","doi-asserted-by":"crossref","first-page":"1233158","DOI":"10.1126\/science.1233158","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Science"},{"key":"10.1038\/mt.2014.152_bib11","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1002\/emmm.201202287","article-title":"Gene therapy on the move","volume":"5","author":"Kaufmann","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1038\/mt.2014.152_bib12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"10.1038\/mt.2014.152_bib13","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","article-title":"Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients","volume":"118","author":"Howe","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2014.152_bib14","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1182\/blood-2011-09-349993","article-title":"Hematopoietic stem cell engineering at a crossroads","volume":"119","author":"Rivi\u00e8re","year":"2012","journal-title":"Blood"},{"key":"10.1038\/mt.2014.152_bib15","doi-asserted-by":"crossref","first-page":"19958","DOI":"10.1073\/pnas.0908528106","article-title":"Reprogramming erythroid cells for lysosomal enzyme production leads to visceral and CNS cross-correction in mice with Hurler syndrome","volume":"106","author":"Wang","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2014.152_bib16","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1073\/pnas.1323155111","article-title":"Platelets are efficient and protective depots for storage, distribution, and delivery of lysosomal enzyme in mice with Hurler syndrome","volume":"111","author":"Dai","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2014.152_bib17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drudis.2006.10.013","article-title":"Blood-brain barrier delivery","volume":"12","author":"Pardridge","year":"2007","journal-title":"Drug Discov Today"},{"key":"10.1038\/mt.2014.152_bib18","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1152\/physrev.00033.2007","article-title":"LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies","volume":"88","author":"Lillis","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1038\/mt.2014.152_bib19","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2174\/092986710790827816","article-title":"Transporters in the brain endothelial barrier","volume":"17","author":"Ueno","year":"2010","journal-title":"Curr Med Chem"},{"key":"10.1038\/mt.2014.152_bib20","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.1222742110","article-title":"Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood-brain barrier","volume":"110","author":"Wang","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2014.152_bib21","doi-asserted-by":"crossref","first-page":"200","DOI":"10.5551\/jat.11.200","article-title":"The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor","volume":"11","author":"Takahashi","year":"2004","journal-title":"J Atheroscler Thromb"},{"key":"10.1038\/mt.2014.152_bib22","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1182\/blood-2006-08-043125","article-title":"Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit","volume":"109","author":"Polavarapu","year":"2007","journal-title":"Blood"},{"key":"10.1038\/mt.2014.152_bib23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev.biochem.71.110601.135342","article-title":"Lipoprotein receptors in the nervous system","volume":"71","author":"Herz","year":"2002","journal-title":"Annu Rev Biochem"},{"key":"10.1038\/mt.2014.152_bib24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.brainres.2007.10.036","article-title":"Progression of multiple behavioral deficits with various ages of onset in a murine model of Hurler syndrome","volume":"1188","author":"Pan","year":"2008","journal-title":"Brain Res"},{"key":"10.1038\/mt.2014.152_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/mthe.1999.0005","article-title":"Long-term and significant correction of brain lesions in adult mucopolysaccharidosis type VII mice using recombinant AAV vectors","volume":"1","author":"Bosch","year":"2000","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2014.152_bib26","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1093\/hmg\/ddq099","article-title":"Widespread enzymatic correction of CNS tissues by a single intracerebral injection of therapeutic lentiviral vector in leukodystrophy mouse models","volume":"19","author":"Lattanzi","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2014.152_bib27","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1038\/mt.2012.118","article-title":"Merits of combination cortical, subcortical, and cerebellar injections for the treatment of Niemann-Pick disease type A","volume":"20","author":"Bu","year":"2012","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2014.152_bib28","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/sj.gt.3302735","article-title":"Intrathecal administration of AAV vectors for the treatment of lysosomal storage in the brains of MPS I mice","volume":"13","author":"Watson","year":"2006","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2014.152_bib29","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/gt.2012.101","article-title":"Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates","volume":"20","author":"Gray","year":"2013","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2014.152_bib30","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/sj.gt.3302961","article-title":"Significantly increased lifespan and improved behavioral performances by rAAV gene delivery in adult mucopolysaccharidosis IIIB mice","volume":"14","author":"Fu","year":"2007","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2014.152_bib31","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/mt.2012.100","article-title":"Sialic acid deposition impairs the utility of AAV9, but not peptide-modified AAVs for brain gene therapy in a mouse model of lysosomal storage disease","volume":"20","author":"Chen","year":"2012","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2014.152_bib32","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1089\/hum.2012.029","article-title":"Correction of pathological accumulation of glycosaminoglycans in central nervous system and peripheral tissues of MPSIIIA mice through systemic AAV9 gene transfer","volume":"23","author":"Ruzo","year":"2012","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2014.152_bib33","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1038\/mt.2013.141","article-title":"Myeloid\/Microglial driven autologous hematopoietic stem cell gene therapy corrects a neuronopathic lysosomal disease","volume":"21","author":"Sergijenko","year":"2013","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2014.152_bib34","first-page":"I","article-title":"The vascular system of the cerebral cortex","volume":"59","author":"B\u00e4r","year":"1980","journal-title":"Adv Anat Embryol Cell Biol"},{"key":"10.1038\/mt.2014.152_bib35","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1523\/JNEUROSCI.4785-13.2014","article-title":"Comparison of five peptide vectors for improved brain delivery of the lysosomal enzyme arylsulfatase A","volume":"34","author":"B\u00f6ckenhoff","year":"2014","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2014.152_bib36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.seminhematol.2009.10.008","article-title":"Transplant outcomes in mucopolysaccharidoses","volume":"47","author":"Prasad","year":"2010","journal-title":"Semin Hematol"},{"key":"10.1038\/mt.2014.152_bib37","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1038\/sj.gt.3301298","article-title":"Retroviral vector design studies toward hematopoietic stem cell gene therapy for mucopolysaccharidosis type I","volume":"7","author":"Pan","year":"2000","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2014.152_bib38","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1073\/pnas.252784899","article-title":"Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB","volume":"100","author":"Ohmi","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2014.152_bib39","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1006\/exnr.2000.7618","article-title":"Turnover of rat brain perivascular cells","volume":"168","author":"Bechmann","year":"2001","journal-title":"Exp Neurol"},{"key":"10.1038\/mt.2014.152_bib40","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1523\/JNEUROSCI.23-12-05197.2003","article-title":"Bone marrow-derived cells that populate the adult mouse brain preserve their hematopoietic identity","volume":"23","author":"Valli\u00e8res","year":"2003","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2014.152_bib41","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1182\/blood-2006-08-036467","article-title":"The macrophage CD163 surface glycoprotein is an erythroblast adhesion receptor","volume":"109","author":"Fabriek","year":"2007","journal-title":"Blood"},{"key":"10.1038\/mt.2014.152_bib42","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuron.2009.11.032","article-title":"Dual roles for perivascular macrophages in immune-to-brain signaling","volume":"65","author":"Serrats","year":"2010","journal-title":"Neuron"},{"key":"10.1038\/mt.2014.152_bib43","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nrn3312","article-title":"Distributed synergistic plasticity and cerebellar learning","volume":"13","author":"Gao","year":"2012","journal-title":"Nat Rev Neurosci"},{"key":"10.1038\/mt.2014.152_bib44","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neubiorev.2014.02.011","article-title":"Moving forward: age effects on the cerebellum underlie cognitive and motor declines","volume":"42","author":"Bernard","year":"2014","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1038\/mt.2014.152_bib45","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/jgm.1141","article-title":"Co-expression of MGMT(P140K) and alpha-L-iduronidase in primary hepatocytes from mucopolysaccharidosis type I mice enables efficient selection with metabolic correction","volume":"10","author":"Wang","year":"2008","journal-title":"J Gene Med"},{"key":"10.1038\/mt.2014.152_bib46","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ymthe.2006.05.014","article-title":"In vivo gene transfer into adult stem cells in unconditioned mice by in situ delivery of a lentiviral vector","volume":"14","author":"Worsham","year":"2006","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2014.152_bib47","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/glycob\/cwg082","article-title":"Improved and simple micro assay for sulfated glycosaminoglycans quantification in biological extracts and its use in skin and muscle tissue studies","volume":"13","author":"Barbosa","year":"2003","journal-title":"Glycobiology"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616302519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616302519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:57:13Z","timestamp":1771606633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616302519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1525001616302519"],"URL":"https:\/\/doi.org\/10.1038\/mt.2014.152","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Normalization and Improvement of CNS Deficits in Mice With Hurler Syndrome After Long-term Peripheral Delivery of BBB-targeted Iduronidase","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mt.2014.152","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society of Gene & Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}